Trial Profile
Trial of varenicline (Champix) for the treatment of spinocerebellar degeneration
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Spinocerebellar degeneration
- Focus Therapeutic Use
- 27 Aug 2013 New trial record